Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Operating Leases: 2022-2024

Historic Operating Leases for Cellebrite DI (CLBT) over the last 3 years, with Dec 2024 value amounting to $11.0 million.

  • Cellebrite DI's Operating Leases rose 26.90% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year increase of 26.90%. This contributed to the annual value of $11.0 million for FY2024, which is 19.79% up from last year.
  • Latest data reveals that Cellebrite DI reported Operating Leases of $11.0 million as of FY2024, which was up 19.79% from $9.2 million recorded in FY2023.
  • Cellebrite DI's 5-year Operating Leases high stood at $11.0 million for FY2024, and its period low was $9.2 million during FY2023.
  • Moreover, its 3-year median value for Operating Leases was $10.4 million (2022), whereas its average is $10.2 million.
  • As far as peak fluctuations go, Cellebrite DI's Operating Leases declined by 11.55% in 2023, and later rose by 19.79% in 2024.
  • Over the past 3 years, Cellebrite DI's Operating Leases (Yearly) stood at $10.4 million in 2022, then dropped by 11.55% to $9.2 million in 2023, then climbed by 19.79% to $11.0 million in 2024.